Peer-reviewedCC BYFrontiers in pharmacology
MolecureAI: an agentic AI platform for autonomous drug discovery
- 1Laboratory of Computer Science and Smart Systems (LISI), Faculty of Sciences Semlalia, Cadi Ayyad University , ,
Related
- Human-Guided Agentic AI for End-to-End EHR Research: Sequential Antibody-Drug Conjugate Pathways in Breast Cancer
- Physics-consistent equation discovery for drug solubility in supercritical CO₂ through symbolic regression and domain generalization
- Advancing the Translational Pipeline: From In Vivo and In Vitro 2D Models to Next-Generation Cell Culture Models for Amyotrophic Lateral Sclerosis Modelling and Drug Discovery
- Design and Characterization of Bovine Serum Albumin Hydrogels: A Promising Platform for Controlled Drug Delivery
- A strategic discovery roadmap towards high-quality leads and drug development candidates for kinetoplastid diseases. Part 3: from lead towards a drug development candidate
BibTeX
@article{chadi2026molecureai,
title = {{MolecureAI: an agentic AI platform for autonomous drug discovery}},
author = {Mohamed Amine Chadi and Asmaa Amzil and Hajar Ezzahoud and Hajar Mousannif},
journal = {Frontiers in pharmacology},
year = {2026},
month = oct,
url = {https://europepmc.org/article/PMC/PMC13658513},
note = {CC BY},
}
RIS
TY - JOUR
TI - MolecureAI: an agentic AI platform for autonomous drug discovery
AU - Mohamed Amine Chadi
AU - Asmaa Amzil
AU - Hajar Ezzahoud
AU - Hajar Mousannif
PY - 2026
DA - 2026/10/16
JO - Frontiers in pharmacology
UR - https://europepmc.org/article/PMC/PMC13658513
SN - 1663-9812
ER -